ERECTILE DYSFUNCTION IN PATIENTS AFTER BRACHYTHERAPY FOR LOCALIZED PROSTATE CANCER: LITERATURE REVIEW


Cite item

Full Text

Abstract

Increasing the number of relatively young men who underwent brachytherapy for localized prostate cancer led to increase the urgency of the issue of quality of life of these patients. Erectile dysfunction (ED) is one of the major factors adversely affecting the quality of life. The high prevalence of erectile dysfunction in patients after brachytherapy, and lack of common approach to effective and safe therapy require more enhanced study of this problem, which is very relevant and important for understanding the etiology, pathogenesis, diagnosis and treatment of ED in men after brachytherapy for localized prostate cancer.

References

  1. Parker SL, Tong T, Bolden S, et al. Cancer statistics 1996. CA Cancer J Clin 1996;46:5.
  2. Stone NN, Stock RG. Complications Following Permanent Prostate Brachytherapy. Eur Urol 2002;41:427-33.
  3. Iversen P, Newling D, Kirby R, Eardley I. Sexual function: Quality of life issues in patients with locally advanced non-metastatic prostate cancer. Eur Urol Suppl 2002;1:26-32.
  4. Litwin MS, Flanders SC, Pasta DJ, et al. Sexual functions and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality of life analysis from CAPSURE. Cancer of the prostate strategic. Urologic Research Endeavor. Urology 1999;54:503.
  5. Ofman US. Sexual quality of life in men with prostate cancer. Cancer 1995;75:1949.
  6. Мазо Е.Б., Гамидов С.И.. Эректильная дисфункция. М. 2004. С. 120.
  7. Nohra J, Delavierre D, Delaunay B, et al. First report on ejaculation after brachytherapy for localised prostate cancer. Eur Urol Suppl 2007;6(2):206.
  8. Iversen P, Newling D, Kirby R,et al. Sexual function: Quality of life issues in patients with locally advanced non-metastatic prostate cancer. Eur Urol Suppl 2002;1:26-32.
  9. Critz FA, Tarlton RS, Holiday DA. Prostate-specific antigen-monitored combination radiotherapy for patients with prostate cancer: 125I implant followed by external-beam radiation. Cancer 1995;75:2383.
  10. Dattoli M, Wallner K, Sorace R, Koala J, Cash J, Awsta R, et al. 103Pd brachytherapy and external beam irradiation for clinically localized high-risk prostatic carcinoma. Int J Radiat Oncol Biol Phys 1996;35:1-5.
  11. Kaye KW, Olson DJ, Payne JT. Detailed preliminary analysis of iodine-125 implantation for localized prostate cancer using percutaneous approach. J Urol 1995;153:1020-25.
  12. Wallner K, Roy J, Harrison L. Tumor control and morbidity following transperineal iodine-125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 1996;14:449-53.
  13. Kao J, Stock RG, Stone NN. Long-term erectile function following real-time ultrasound-guided brachytherapy for prostate cancer. J Urol 2000;163:1276.
  14. Incrocci L, van der Wielen GJ. Erectile Function after Prostate Brachytherapy. Eur Urol 2007;52:282-3.
  15. Mabjeesh N, Beri A, Stenger et al. Erectile function after permanent prostate brachytherapy: Long-term results. Eur Urol Suppl 2004;3:33.
  16. Merrick GS, Galbreath RW, Butler WM, et al. Erectile Function After Prostate Brachytherapy. J Urol 2006;175:959-60.
  17. Seftel AA. Erectile Function After Prostate Brachytherapy. J Urol 2005;174:2299-300.
  18. Anderson RL, Merrick GS, Butler WM, et al. Erectile function following permanent prostate brachytherapy: Results of two prospective randomized trials. Int J Radiat Oncol Biol Phys 2004;60:453.
  19. Taira AV, Merrick GS, Galbreath RW, et al. Erectile function durability following permanent prostate brachytherapy. Brachytherapy 2009;8:168.
  20. Pinkawa M, Gagel B, Piroth MD, et al. Erectile dysfunction after external beam radiotherapy for prostate cancer. Eur Urol 2009;55:227-36.
  21. Hirsh AZ, Yan W, Castano E, et al. Acute/Late Toxicities and Predictors of Erectile Function in Patients with Intermediate Risk Prostate Cancer Treated with Combined Modality External Beam Radiotherapy and Interstitial Brachytherapy. Int J Radiat Oncol Biol Phys 2008;72:499.
  22. Sarosdy MF. Hypogonadism is more common than expected in men about to undergo prostate brachytherapy, independent of age and degree of erectile dysfunction. Brachytherapy 2006;5:107.
  23. Seideman CA, Morgenstern C, Napolitano B, et al. Physics 2008;72:95.
  24. Keyes M, MacDonald G, Krukz A, et al Predictive Factors for Erectile Dysfunction in Men with Prostate Cancer Following Prostate Brachytherapy: Is Dose to the Penile Bulb Important? J Radiother Oncol 2005;76:6.
  25. Lief JH, Merrick GS, Butler WM, et al. Correlation between radiation dose to the proximal penis and the development of brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2002;54:111-2.
  26. Nava LD, Losa A, Cardone G, et al. Magnetic resonance angiography imaging for neurovascular bundles dosimetry after permanent prostate brachytherapy: A tool to prospectively improve the evaluation of the impact of dosimetry on erectile function. Eur Urol Suppl 2005;4:42.
  27. Nohra J, Delaunay B, Delannes M, et al. Sexuality after brachytherapy for localised prostate cancer: long-term results. Eur Urol Suppl 2008;7(3):163.
  28. Merrick GS, Butler WM, Wallner KE, et al. Erectile function after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005;62:437-47.
  29. Merrick GS, Butler WM. The dosimetry of brachytherapy-induced erectile dysfunction. Med Dosim 2003;28:271-74.
  30. Kassabian AA, Bar-Chama N, Stone NN, et al. The impact of hormonal therapy on erectile function in potent men who underwent I-125 brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2004;60:268-69.
  31. Schiff J, Bar-Chama N, Cesaretti J, et al. Neo-adjuvant and adjuvant hormone suppression therapy adversely impacts erectile function after brachytherapy. Fertility and Sterility 2006;86:28-9.
  32. Huyghe E, Nohra J, Delavierre D, et al. Plante P. Erectile function after brachytherapy for localized prostate cancer: long-term results. Eur Urol Suppl 2007;6(2):206.
  33. Merrick GS, Butler WM, Galbreath RW, et al. Erectile function after permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2002;52:893-902.
  34. Patil NG, Aneja M, Zhou D, et al. Prospective Evaluation of Erectile Function using International Index of Erectile Function (IIEF-5) Score after Iodine-125 Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2008;72:294.
  35. Merrick GS, Butler WM, Dorsey AT, et al. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction. Int J Radiat Oncol Biol Phys 2000;48:1069-74.
  36. Solan AN, Stock RG, Cesaretti JA, et al. Correlation Between Erectile Dysfunction and Dose to Penile Bulb and Neurovascular Bundles Following Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2007;69:351-52.
  37. Kiteley RA, Lee WR, de Guzman AF, et al. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy. Brachytherapy 2002;1:90-4.
  38. Wright JL, Newhouse JH, Laguna JL, et al. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2004;59:426-35.
  39. Stone NN, Cesaretti JA, Rosenstein B, et al. Do high radiation doses in locally advanced prostate cancer patients treated with 103Pd implant plus external beam irradiation cause increased urinary, rectal, and sexual morbidity? Brachytherapy 2010;9(2):114-18.
  40. Stipetich R, Abel LJ, Anderson RL, et al. Nursing considerations in brachytherapy-related erectile dysfunction. Urol Nurs 2005;25:249-54.
  41. Lue TF. Erectile dysfunction. N Engl J Med 2000;324:1801-13.
  42. Schulz CA, Hendee E, Odau H, et al. Erectile dysfunction and brachytherapy-related doses to the neurovascular bundles. Int J Radiat Oncol Biol Phys 2000;48:250.
  43. Bradley KA, Chappell R, Yuan Z, et al. Erectile dysfunction and prostate brachytherapy doses to the penile bulb and neurovascular bundles. Int J Radiat Oncol Biol Phys 2003;57:399-400.
  44. Losa A, Nava L, Maga T, et al. Quality of life and sexual function after palladium 103 prostate brachytherapy. Eur Urol Suppl 2002;1:46.
  45. Sooriakumaran P, Henderson A, Khaksar S, et al. Effects of brachytherapy on erectile function. Prospective UK data. Eur Urol Suppl 2005;3:82.
  46. Machtens S, Baumann R, Karstens JH, et al. Long-term erectile function after LDR-brachytherapy with iodine-125 for the treatment of localised prostate cancers. Eur Urol Suppl 2006;5(2):171.
  47. Rotella DP. Phosphodiesterase 5 inhibitors: current status and potential applications. Nat Rev Drug Discov 2002;1:674-82.
  48. Canada AL, Neese LE, Sui D, et al. Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 2005;104:2689-700.
  49. Pahlajani G, Raina R, Phillippi A, et al. Early Intervention with PDE-5 Inhibitors Following Prostate Brachytherapy Improves Subsequent Erectile Function. Int J Radiat Oncol Biol Phys 2008;72:503.
  50. Shemtov OM, Radomski SB, Crook J. Success of sildenafil for erectile dysfunction in men treated with brachytherapy or external beam radiation for prostate cancer. Can J Urol 2004;11:2450-55.
  51. Montorsi F, Maga T, Strambi L, et al. Sildenafil taken at bedtime significantly increase nocturnal erection results of a placebo-controlled study. J Urol 2000;56:906-11.
  52. Montorsi F, Salonia A, Briganti A, et al. Vardenafil for the treatment of erectile dysfunction: a critical review of the literature based on personal clinical experience. Eur Urol 2005;47:612-21.
  53. Merrick GS, Butler WM, Lief JH, et al. Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urol 1999;53:1112-16.
  54. Montorsi F, Verheyden B, Meuleman E, et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol 2004;45:339-44.
  55. Pahlajani G, Raina R, Jones JS, et al. Early intervention with phosphodiesterase-5 inhibitors after prostate brachytherapy improves subsequent erectile function. BJU Int 2010;12.
  56. Incrocci L, Slagter C, Slob AK, et al. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis®) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 2006;66(Suppl):38-9.
  57. Park JL, Cesaretti JA, Kao J, et al. Vardenafil is more efficacious than tadalafil for patient's who requested an alternative to sildenafil following prostate brachytherapy. Int J Radiat Oncol Biol Phys 2006;3(66)(Suppl):540.
  58. Rosenberg MT, Adams PL, McBride TA, et al. Improvement in duration of erection following phosphodiesterase type 5 inhibitor therapy with vardenafil in men with erectile dysfunction: the ENDURANCE study. Int J Clin Pract 2009;63:27-34.
  59. Lehrer S, Cesaretti J, Stone NN, et al. Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation. BJU Int 2006;98:979-81.
  60. Donath D, Delouya G, Lefebvre F, et al. The Relationship between Erectile Function and Lower Urinary Tract Symptoms in Patients Treated with Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 2009;75:337.
  61. Peltier A, van Velthoven R, Roumeguare T. Current management of erectile dysfunction after cancer treatment. Curr Opin Oncol 2009;21(4):303-09.
  62. Nehra A, Blute ML, Barrett DM, et al. Rationale for combination therapy of intraurethral prostaglandin E (1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int j Impot Res 2002;14:38-42.
  63. Brock G, Tu LM. Return of spontaneous erection during long-term intracavernosal alprostadil (Caverject) treatment. Urol 2001;57:536-41.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies